BioCardia (BCDA) Assets Growth (5y) (2015 - 2026)
Powered by 
Analysis
BioCardia (BCDA) Assets Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.73 Bn | 3.44 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.62 Bn | 2.66 Bn | 251.50 Mn |
| 5 | uniQure | 2.99 Bn | 2.99 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.25 Bn | 1.46 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.13% |
| Mar 31, 2026 | -40.68% |
| Dec 31, 2025 | -31.97% |
| Sep 30, 2025 | -8.34% |
| Jun 30, 2025 | -30.76% |
| Mar 31, 2025 | -13.15% |
| Dec 31, 2024 | -13.47% |
| Sep 30, 2024 | -10.11% |
| Jun 30, 2024 | 1.25% |
| Mar 31, 2024 | -12.28% |
| Dec 31, 2023 | -14.18% |
| Sep 30, 2023 | -7.58% |
| Jun 30, 2023 | -3.57% |
| Mar 31, 2023 | -7.30% |
| Dec 31, 2022 | -6.27% |
| Sep 30, 2022 | -10.36% |
| Jun 30, 2022 | -8.70% |
| Mar 31, 2022 | -8.28% |
| Dec 31, 2021 | -6.57% |
| Dec 31, 2020 | 36.95% |